Neuropathology B – NPB
Review Branch Summary
The Neuropathology B Review Branch reviews applications that focus on neurodegenerative diseases. Applications may span genetic, molecular and cellular approaches to mechanistic, translational and human-subject based studies to examine the etiology, pathogenesis and management of these diseases and disorders. These neurodegenerative diseases include but are not limited to Alzheimer’s disease and Alzheimer's disease-related dementias, Parkinson’s disease and other movement disorders (Huntington’s disease (HD), dystonia, dyskinesia, and ataxias); and Amyotrophic Lateral Sclerosis and related motor neuron disorders. In addition, the NPB review branch also has study sections that examine neuroimmune function and inflammation in neurodegenerative diseases, environmental factors which may lead to disease as well as therapeutic development for neurodegeneration. Applications may be mechanistic, preclinical, translational or clinical in nature and use animal, non-human primates or human subjects and/or specimens.
Study Sections
- Molecular and Cellular Underpinnings and Integrative Neuropathophysiology of Alzheimer’s Disease and Related Dementia (ADRD) Ends with Spring 2026 review meetings (May 2026 Advisory Council)
AN (55)
- Metabolic, Cerebrovascular, Environmental, and Sleep Factors in Alzheimer’s Disease and Related Dementias (ADRD) Ends with Spring 2026 review meetings (May 2026 Advisory Council)
AN (55)
- Neuroimmune Dysregulation and Neuroinflammation in Alzheimer’s Disease and Related Dementias (ADRD) and Neurodegeneration Ends with Spring 2026 review meetings (May 2026 Advisory Council)
AN (55)
- New! Cellular Mechanisms of Neurodegeneration *Begins October 2026 Council Round (Cycle I due dates).
CMN
- Cellular and Molecular Biology of Neurodegeneration Ends with Spring 2026 review meetings (May 2026 Advisory Council)
CMND
- Chronic Dysfunction and Integrative Neurodegeneration Ends with Spring 2026 review meetings (May 2026 Advisory Council)
CDIN
- New! Integrative Approaches in Neurodegeneration *Begins October 2026 Council Round (Cycle I due dates).
IAN
NICT
- Special Emphasis Panel: Therapeutic Development for Neurological Disorders NPB (56)
- Special Emphasis Panel: Integrated Preclinical and Translational Research in Neurodegenerative Diseases NPB (57)
- New! Special Emphasis Panel: Environmental Factors, Brain Injury and Glia in Neurodegeneration *Begins October 2026 Council Round (Cycle I due dates).
NPB (58)
- New! Proteostasis and Protein Aggregation in Neurodegeneration *Begins October 2026 Council Round (Cycle I due dates).
PPAN
RFN
- Fellowships: Alzheimer’s and Neurodegeneration F02
- Training and Career Development: Neurodegeneration T02
- Small Business: Small Molecule Therapeutic Development for Alzheimer’s Disease, Related Dementias and Neurodegenerative Disorders NPB (10)
- Small Business: Biologic-based Therapeutic Development for Alzheimer’s Disease, Related Dementias and Neurodegenerative Disorders NPB (11)
